Search in:

Drug Design, Development and Therapy Volume 11, 2017 - Issue

Submit an article Journal homepage

Open access

101

Views

CrossRef citations to date

Altmetric

Review

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

Chunlan Zheng1 Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute)

Xiufen Hu2 Department of Paediatrics, Tongji Hospital

Li Zhao1 Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute)

Minhui Hu1 Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute)

Feng Gao3 Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence[email protected]

Pages 2957-2968 | Published online: 11 Oct 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Baljinder Singh. (2023) Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review. Current Molecular Pharmacology 16:3, pages 243-253.
Crossref

Peggy Gandia, Sarah Decheiver, Manon Picard, Romain Guilhaumou, Sarah Baklouti & Didier Concordet. (2023) Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades. Antibiotics 12:3, pages 515.
Crossref

Tianwen Yao, Qingliang Wang, Shisheng Han, Yan Lu, Yanqiu Xu & Yi Wang. (2022) Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking. BioMed Research International 2022, pages 1-16.
Crossref

Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati & Pooja Chawla. (2022) Discovery and Development of Antibacterial Agents: Fortuitous and Designed. Mini-Reviews in Medicinal Chemistry 22:7, pages 984-1029.
Crossref

Hung-Ling Huang, Wei-Chang Huang, Kun-Der Lin, Shin-Shin Liu, Meng-Rui Lee, Meng-Hsuan Cheng, Chun-Shih Chin, Po-Liang Lu, Chau-Chyun Sheu, Jann-Yuan Wang, I-Te Lee & Inn-Wen Chong. (2021) Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study. Clinical Infectious Diseases 73:6, pages e1252-e1260.
Crossref

Shu-Yung Lin, Jia-Yih Feng, Chih-Yuan Lee, Yi-Chih Lin, Yu-Hsiang Chou, Kuan-Yin Lin, Yu-Feng Wei, Shu-Wen Lin, Chin-Hao Chang, Ping-Huai Wang, Chin-Chung Shu, Jann-Yuan Wang & Chong-Jen Yu. (2021) Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study. Antimicrobial Agents and Chemotherapy 65:3.
Crossref

Elizabeth D. Kim, Catherine D. Kim, Joseph Chaney & Sunyoung Kim. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III 27 43 .

Théoneste Umumararungu, Marie Jeanne Mukazayire, Matabishi Mpenda, Marie Françoise Mukanyangezi, Jean Bosco Nkuranga, Janvier Mukiza & Emmanuel Oladayo Olawode. (2020) A review of recent advances in anti-tubercular drug development. Indian Journal of Tuberculosis 67:4, pages 539-559.
Crossref

Shetty Ravi Dyavar, Timothy M. Mykris, Lee C. Winchester, Kimberly K. Scarsi, Courtney V. Fletcher & Anthony T. Podany. (2020) Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics. Scientific Reports 10:1.
Crossref

T. I. MOROZOVА & O. N. OTPUSCHENNIKOVА. (2019) EXPERIENCE OF USING RIFAPENTINE IN CONTINUATION PHASE OF TREATMENT OF ADULT TUBERCULOSIS CASES. TUBERCULOSIS AND LUNG DISEASES 97:6, pages 31-35.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date